Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ROSLACT Bolus is a veterinary pharmaceutical product developed by Rosetta Lifecare, formulated as a rumen stimulant and digestive supplement for livestock, including cattle, buffalo, sheep, and goats. The product is a multi-ingredient combination typically containing probiotics such as *Saccharomyces cerevisiae* and *Lactobacillus sporogenes*, fungal enzymes like *Aspergillus oryzae*, amino acids (e.g., DL-Methionine), and essential trace minerals including Cobalt, Copper, and Zinc. It is indicated for the treatment of anorexia, indigestion, and rumen dysfunction, and is used to restore rumen microflora balance and enhance milk production in dairy animals. As a finished commercial veterinary formulation, it is marketed for use in livestock, pets, and poultry categories.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ROSLACT Bolus.